2023 annual financial data
Virax Biolabs Group 2023 Operating margin
Virax Biolabs Group 2023 operating margin with verified reported values.
Direct answer
Operating margin was -66,963.67%.
Operating income was -5,732,760 USD and net income was -5,457,494 USD.
Operating cash flow was -4,179,767 USD.
Get free Virax Biolabs Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,561 USD
- Operating income
- -5,732,760 USD
- Net income
- -5,457,494 USD
- Operating cash flow
- -4,179,767 USD